BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27

• Job Trends

  Dendreon Corporation Slashes 15 Percent Of Jobs As Provenge Sales Disappoint

  November 12, 2013

   · 

  1 min read
• Drug Development

  PsiOxus Therapeutics Limited Cancer-Wasting Drug Better Than Placebo In Phase 2 Study

  November 12, 2013

   · 

  4 min read
• Lone Star Bio

  Cerebain Biotech Announces Next Major Step In Its Fight Against Alzheimers

  November 12, 2013

   · 

  1 min read
• Gyros AB Immunoassay Platform Selected By BioAgilytix Labs To Support Bioanalysis Services

  November 12, 2013

   · 

  3 min read
• Business

  GW Pharmaceuticals To Report 2013 Q4 And Full Year Financial Results And Host Conference Call On 19 November, 2013

  November 12, 2013

   · 

  1 min read
• Drug Development

  CEL-SCI Receives Croatian Government Approval to Commence Phase 3 Clinical Trial Of Multikine In Head And Neck Cancer

  November 12, 2013

   · 

  1 min read
• Lone Star Bio

  Opexa Therapeutics Selected As A “Top 10 Advanced Therapy Projects To Watch”

  November 12, 2013

   · 

  1 min read
• Drug Development

  Eleven Biotherapeutics To Present Clinical Data On Lead Drug Candidate, EBI-005

  November 12, 2013

   · 

  1 min read
• Drug Development

  Antegrin Announces Publication In Nature Medicine Of Preclinical Data In Fibrosis Models

  November 12, 2013

   · 

  1 min read
• BioMidwest

  Orexigen Therapeutics, Inc. And Orexigen Therapeutics, Inc. Announce Multiple Contrave Data Presentations At The Obesityweek Meeting In Atlanta

  November 12, 2013

   · 

  9 min read